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Case Report
Adult Laryngeal Hemangioma
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Abstract
Adult laryngeal hemangioma is rare, and very few reports of such lesions 
restricted to the aryepiglottic fold have appeared in the medical litera-
ture. We report a hemangioma located over the left aryepiglottic fold in 
a 57-year-old man. This patient had experienced a lump-in-the-throat sen-
sation for 1 year but complained of no other symptoms. On laryngoscopy, 
a lobulated dark-red mass was seen over the left aryepiglottic fold. A 
potassium-titanyl-phosphate laser excision was performed smoothly with-
out complications. The 6-month postoperative follow-up showed good 
results with no recurrence. An adult supraglottic laryngeal hemangioma 
is rare and can be treated successfully with a KTP laser. [Tzu Chi Med J 
2010;22(4):237–240]
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1. Introduction
Hemangioma is not uncommon and presents as the 
most common infantile tumor, but it is rare in adults 
[1]. The incidence of this tumor is higher in the head 
and neck region among patients of all ages [2]. The 
tumor is self-limited and resolves in approximately half 
of children by 5 years of age, and resolves further with 
age. In contrast, in adults, hemangioma is rare and 
does not regress spontaneously [3]. The manifestations 
depend on the lesion’s site, and the morphology also 
introduces potential complications [4]. Whenever the 
aerodigestive tract is involved, clinical presentations 
such as bleeding, airway compromise, or dysphagia 
should be anticipated. Even though there is no eluci-
dative prognosis with/without a surgical procedure, the 
management goal lies in prevention of life-threatening 
complications. In this report, we present a patient with 
a cavernous hemangioma of the left aryepiglottic fold. 
To the best of our knowledge, very few such cases have 
been reported in the medical literature.
2. Case report
A 57-year-old man came to our hospital for a routine 
health examination. On physical examination, a lob-
ulated dark red tumor was found over the left aryepi-
glottic fold (Fig. 1). He reported a persistent sensation 
of a lump in the throat for 1 year. But since it had not 
become worse, he had not sought any medical therapy. 
The patient did not have symptoms such as dysphagia, 
odynophagia, choking, oral bleeding, hemoptysis, or 
dyspnea. The medical history showed nothing signifi-
cant. He had no history of smoking or alcohol use. As 
we were concerned about the risk of spontaneous rup-
ture or airway compromise if the hemangioma of the 
larynx was left untreated, surgery was recommended.
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One week later, laryngomicrosurgery was performed 
under general anesthesia, and the hemangioma was 
completely removed with a potassium-titanyl-phosphate 
(KTP) laser. The tumor was grasped with a cup forceps 
to expose its wide-based stump. It was coagulated 
around its stump without excessive bleeding. Then, the 
stump was coagulated again at low power (4 watts) 
without injuring the false cord or the vocal ligament. 
A small cotton ball soaked with epinephrine was used 
to stop bleeding, and the minimal oozing that remained 
was easily controlled by compression and cauteriza-
tion. He was discharged 1 day later and followed-up 
regularly thereafter. His postoperative course was very 
smooth, and no recurrence was noted over the sub-
sequent 6 months (Figs. 2 and 3).
The histologic results showed a hemangioma with 
increased density, blood-filled abnormally dilated and 
tortuous vessels with an irregular wall thickness within 
a loose fibrous stroma. The pathology report was 
compatible with cavernous hemangioma (Fig. 4).
3. Discussion
Hemangiomas of the larynx are generally classified 
into adult and infantile types. Infantile hemangiomas 
are usually subglottic and may cause fluctuating res-
piratory distress and biphasic stridor, especially dur-
ing periods of venous engorgement. They sometimes 
accompany cutaneous hemangiomas [5]. Adult he-
mangiomas are rare and can be seen at various sites, 
but are usually glottic or supraglottic. They are more 
often of cavernous form and cause vague symptoms 
[6,7], such as hoarseness, cough, hemoptysis, dysp-
nea, and a lump sensation, as in our patient.
Fig. 1 — Preoperative view shows a lobulated dark red 
tumor over the left aryepiglottic fold.
Fig. 2 — Postoperative view shows formation of fibrin 
1 week after surgery.
Fig. 3 — Postoperative view shows formation of smooth 
mucosa covering the site 1 month after surgery.
Fig. 4 — The tumor is covered with squamous epithelium. 
Increased, abnormally dilated and tortuous vessels with 
an irregular wall thickness within a loose fibrous stroma 
are clearly seen. The findings are compatible with cavern-
ous hemangioma. (Hematoxylin & eosin, 100´.)
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According to the International Society for the Study 
of Vascular Anomalies, vascular anomalies encom-
pass hemangiomas and vascular malformations. The 
former are characterized by a growth phase, hyper-
cellularity, and endothelial proliferation, whereas the 
latter are congenital lesions that are differentiated 
from hemangiomas on the basis of their normal en-
dothelial cell turnover and lack of excessive prolifer-
ation. Malformations have abnormal structures derived 
from vessels and generally do not regress [8]. Histo-
logically, hemangiomas are composed of large, irregu-
lar, blood-filled channels lined with a single layer of 
endothelial cells between loose fibrous tissue septa 
of varying thickness. The exact etiology of the origin of 
hemangiomas is not well understood. Most hemangi-
omas are congenital and slowly progressive, with 85% 
of cases noted by 1 year of age. Among hemangiomas, 
65% occur in the head and neck region [9].
Laryngeal hemangiomas are diagnosed primarily 
by physical examination and history. Doppler ultra-
sound, computed tomography, technetium imaging, 
and plain radiographs can play a role in determining 
the dimensions and extent of hemangiomas [10]. If the 
lesion is extensive, angiography and magnetic reso-
nance imaging may be useful in confirming the vas-
cular nature of an adult laryngeal hemangioma as well 
as in determining its extent. Our patient did not un-
dergo any imaging study because the hemangioma 
was isolated and appeared to be restricted to the left 
aryepiglottic fold under flexible laryngoscopy.
There is no well-established treatment protocol for 
adult laryngeal hemangiomas because only anecdo-
tal case reports or very limited series are available in 
the medical literature. Injection of corticosteroids or 
ethanol, cryosurgery, and radiation therapy have been 
used. For small lesions, excision with microlaryngo-
scopic techniques can be used. For large lesions, tra-
cheostomy and an open surgical approach may be 
required. Laser surgery is thought to be relatively ef-
fective and less invasive than surgical removal. CO2 
laser excision of the lesion is generally accepted. In 
limited or pedunculated supraglottic cavernous he-
mangiomas, CO2 laser vaporization of the lesion with 
super-pulse modality at 4–8 W is advised [7]. But CO2 
laser cauterization is ineffective in extended lesions 
and in large vessels with significant bleeding. Extended 
laryngeal hemangiomas involving the hypopharynx 
should be approached with staged laser surgical pro-
cedures to avoid postoperative laryngeal inflammation 
and edema [7]. Several reports indicate that use of 
the CO2 laser when treating subglottic hemangiomas 
has been associated with increased risk of damage to 
adjacent mucosa and an increased risk of develop-
ment of subglottic stenosis postoperatively [11].
Available data on the use of KTP lasers in the 
management of laryngeal hemangiomas are limited. 
We applied a KTP laser to ablate this vascular tumor 
because it has several advantages. The KTP laser 
beam is preferentially absorbed by hemoglobin, which 
makes this laser system applicable to the treatment 
of hemangiomas. It can be directed by fiberoptic fib-
ers to the tissues by both handheld instruments and 
microscope attachments; thus, it is very adaptable and 
precise. KTP laser-assisted excision, being a minimally 
invasive approach, results in minimal blood loss. Ad-
ditionally, the fibers can be used in both contact and 
non-contact modes without interruption of the laser. 
In this case, we used the KTP laser to successfully re-
move the laryngeal hemangioma without complications 
and there was no recurrence at the 6-month postop-
erative follow-up. The KTP laser has had versatile clin-
ical applications in treating extralaryngeal vascular 
lesions, such as esophageal hemangioma [12], ure-
thral hemangioma [13], pyriform fossa hemangioma 
[14], superficial cutaneous vascular lesions [15], and 
intralesional photocoagulation for voluminous vascular 
lesions of the skin [16].
In conclusion, an adult supraglottic laryngeal he-
mangioma is rare and can be treated successfully 
with a KTP laser with limited morbidity. The KTP laser 
is a good tool for the management of laryngeal he-
mangioma with a low incidence of complications.
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